Form4insider filings, from the source

SEC Form 4 · accession 0001209191-18-001502

ChemoCentryx, Inc. · CCXI

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Markus J. Cappel
Officer — Chief Bus. Officer & Treasurer
Period of report
Jan 1, 2018
Accepted (ET)
Jan 3, 2018 · 7:31 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001340652

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockJan 1, 2018M8,333$0.00A24,724D
Common StockJan 1, 2018M10,000$0.00A34,724D
Common StockF3Jan 1, 2018F10,898$5.95D23,826D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock UnitsF4,F5—Jan 1, 2018M8,333D——Common Stock8,3338,334D
Restricted Stock UnitsF4,F6—Jan 1, 2018M10,000D——Common Stock10,00020,000D

Explanation of responses